Skip to content

Efficacy of Furosemide versus KOH topical gels in treatment warts

Efficacy of Furosemide 0.125 % topical gel and KOH 10% topical gel in treatment of patients with warts

Status
Recruiting
Phases
Phase 3
Study type
Interventional
Source
IRCT
Registry ID
IRCT20120524009844N9
Enrollment
40
Registered
2021-05-18
Start date
2021-05-22
Completion date
Unknown
Last updated
2021-05-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Non-genital warts. Viral wart, unspecified

Interventions

Intervention group: In each patient, after examining the warts and relative matching according to the size and location, some of the warts will be treated with topical furosemide and some with 10% KOH

Sponsors

Tabriz University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
7 Years to 60 Years

Inclusion criteria

Inclusion criteria: Having at least 2 non-genital and non-flat warts Satisfaction with the study Age between 7 and 60 years

Exclusion criteria

Exclusion criteria: Pregnant and beast feeder women Receive effective treatments for warts in the last 30 days Having underlying cardiovascular, pulmonary or renal disease

Design outcomes

Primary

MeasureTime frame
Number of warts. Timepoint: At the beginning of the study, 4 and 8 weeks after the intervention. Method of measurement: Physical examination.;Diameter of warts. Timepoint: At the beginning of the study, 4 and 8 weeks after the intervention. Method of measurement: Clinical examination and measurement with caliper.;Height of warts. Timepoint: At the beginning of the study, 4 and 8 weeks after the intervention. Method of measurement: Clinical examination and measurement with caliper.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactMehdi Amirnia

Tabriz University of Medical Sciences

amirniam@tbzmed.ac.ir+98 41 1540 6612

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026